Trials / Conditions / Leukemia, Myelogenous, Chronic

Leukemia, Myelogenous, Chronic

9 registered clinical trials studyying Leukemia, Myelogenous, Chronic.

Status	Trial	Sponsor	Phase
Completed	A Bioequivalence Study of Dasatinib Tablet NCT05640804	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 1
Completed	Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) NCT03421626	Cepheid	—
Completed	Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Ce NCT02117115	Washington University School of Medicine	EARLY_Phase 1
Completed	Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant NCT01720264	Sherif S. Farag	Phase 2
Completed	Sitagliptin Umbilical Cord Blood Transplant Study NCT00862719	Indiana University School of Medicine	Phase 2
Terminated	A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With My NCT00569179	Indiana University School of Medicine	Phase 1
Completed	Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies NCT00619879	Ann & Robert H Lurie Children's Hospital of Chicago	—
Completed	Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) NCT00129740	M.D. Anderson Cancer Center	Phase 2
Completed	Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malign NCT00241358	Washington University School of Medicine	Phase 1 / Phase 2